» Articles » PMID: 27401188

Is There a Relation Between Pre-sarcopenia, Sarcopenia, Cachexia and Osteoporosis in Patients with Ankylosing Spondylitis?

Overview
Publisher Biomed Central
Specialties Orthopedics
Physiology
Date 2016 Jul 13
PMID 27401188
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Osteoporosis is a well-known complication of ankylosing spondylitis (AS). However, data about body composition modifications and muscle performance showed conflicting results. The aim of the study was to determine the prevalence and risk factors of pre-sarcopenia, sarcopenia and cachexia in patients with AS and analyze its relationship with bone loss and symptomatic and severity parameters of the disease.

Methods: Sixty-seven consecutive male patients with AS (mean age of 40.9 ± 11.0 years) and 67 healthy controls were studied. Body composition and bone mineral density (BMD) scans were obtained using DXA. The fat-free mass index (FFMI; fat-free mass divided by height squared) and the percent of fat mass (%FM) were calculated. Pre-sarcopenia was defined by low skeletal muscle mass (SMI <7.25 kg/m(2)), sarcopenia by the combined presence of the two following criteria: SMI <7.25 kg/m(2) and a low muscle strength (handgrip strength <30 kg) or a low muscle performance (timed get-up-and-go test >10 s) and cachexia by a BMI <20 kg/m(2) plus 3 from the 5 following parameters: anorexia, fatigue, handgrip strength <30 kg, CRP >5 mg/l, SMI <7.25 kg/m(2).

Results: Pre-sarcopenia, sarcopenia, cachexia, and osteoporosis prevalences were (50.4, 34.3, 11.9, and 16.0) respectively. Patients had a mean 3 kg significant decrease in FFM and a 1 kg/m(2) decrease in appendicular mass vs. healthy controls. Pre-sarcopenia, sarcopenia and cachexia were significantly associated to higher BASDAI levels and low BMD.

Conclusion: Our study showed that men with AS had a statistically significant reduction in total and appendicular lean mass that is related to higher disease activity and significantly associated to bone loss.

Citing Articles

Assessment of sarcopenia in young patients with inflammatory arthritis: a cross-sectional study.

Kulyk M, Dzhus M Sci Rep. 2025; 15(1):8236.

PMID: 40064969 PMC: 11893876. DOI: 10.1038/s41598-025-88939-9.


Rebuttal on the comment on "Age, body mass index, and function as the independent predictors of sarcopenia in axial spondyloarthritis: a cross-sectional analysis".

Chaiamnuay S Clin Rheumatol. 2024; 43(7):2373-2374.

PMID: 38809283 DOI: 10.1007/s10067-024-07018-y.


The prevalence of sarcopenia in spondyloarthritis patients: a meta-analysis.

Hu J, Wang Y, Ji X, Zhang Y, Li K, Huang F Arthritis Res Ther. 2024; 26(1):72.

PMID: 38493139 PMC: 10943775. DOI: 10.1186/s13075-024-03299-5.


Age, body mass index, and function as the independent predictors of sarcopenia in axial spondyloarthritis: a cross-sectional analysis.

Kanjanavaikoon N, Saisirivechakun P, Chaiamnuay S Clin Rheumatol. 2023; 42(12):3257-3265.

PMID: 37755546 DOI: 10.1007/s10067-023-06770-x.


Prevalence of Sarcopenia in Africa: A Systematic Review.

Mballa Yene B, Lee S, Park K, Kang Y, Seo S, Yoo J Clin Interv Aging. 2023; 18:1021-1035.

PMID: 37427010 PMC: 10329476. DOI: 10.2147/CIA.S407917.


References
1.
Marcora S, Chester K, Mittal G, Lemmey A, Maddison P . Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr. 2006; 84(6):1463-72. DOI: 10.1093/ajcn/84.6.1463. View

2.
Maillefert J, Aho L, Maghraoui A, Dougados M, Roux C . Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study. Osteoporos Int. 2001; 12(7):605-9. DOI: 10.1007/s001980170084. View

3.
Lainscak M, Filippatos G, Gheorghiade M, Fonarow G, Anker S . Cachexia: common, deadly, with an urgent need for precise definition and new therapies. Am J Cardiol. 2008; 101(11A):8E-10E. DOI: 10.1016/j.amjcard.2008.02.065. View

4.
Plasqui G, Boonen A, Geusens P, Kroot E, Starmans M, van der Linden S . Physical activity and body composition in patients with ankylosing spondylitis. Arthritis Care Res (Hoboken). 2012; 64(1):101-7. DOI: 10.1002/acr.20566. View

5.
Sveaas S, Berg I, Provan S, Semb A, Olsen I, Ueland T . Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study. Scand J Rheumatol. 2015; 44(2):118-24. DOI: 10.3109/03009742.2014.956142. View